Safety and efficacy of FOLFIRINOX in elderly patients with metastatic or locally advanced pancreatic adenocarcinoma: A retrospective analysis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Lepage, 2015, Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999-2007: results of EUROCARE-5, Eur J Cancer Oxf Engl 1990, 51, 2169
Burris, 1997, Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial, J Clin Oncol Off J Am Soc Clin Oncol, 15, 2403, 10.1200/JCO.1997.15.6.2403
Conroy, 2011, FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer, N Engl J Med, 364, 1817, 10.1056/NEJMoa1011923
Gourgou-Bourgade, 2013, Impact of FOLFIRINOX compared with gemcitabine on quality of life in patients with metastatic pancreatic cancer: results from the PRODIGE 4/ACCORD 11 randomized trial, J Clin Oncol Off J Am Soc Clin Oncol, 31, 23, 10.1200/JCO.2012.44.4869
Berretta, 2013, Oxaliplapin and capecitabine (XELOX) based chemotherapy in the treatment of metastatic colorectal cancer: the right choice in elderly patients, Anticancer Agents Med Chem, 13, 1344, 10.2174/18715206113136660347
Moorcraft, 2014, FOLFIRINOX for locally advanced or metastatic pancreatic ductal adenocarcinoma: the Royal Marsden experience, Clin Colorectal Cancer, 13, 232, 10.1016/j.clcc.2014.09.005
Hosein, 2012, A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma, BMC Cancer, 12, 199, 10.1186/1471-2407-12-199
Gunturu, 2013, FOLFIRINOX for locally advanced and metastatic pancreatic cancer: single institution retrospective review of efficacy and toxicity, Med Oncol N Lond Engl, 30, 361, 10.1007/s12032-012-0361-2
Peddi, 2012, Multi-institutional experience with FOLFIRINOX in pancreatic adenocarcinoma, JOP J Pancreas, 13, 497